William Atallah, MD

William Atallah, MD, MPH specializes in endourology and urinary stone disease. He treats kidney stones using a variety of techniques such as Extracorporeal Shockwave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy and Mini-Percutaneous Nephrolithotomy.  Besides treatment of the stone, Dr Atallah focuses on kidney stone prevention using dietary changes.  He also treats patients with flank pain, upper tract urothelial cancer, hydronephrosis, blood in the urine, difficulty urinating, slow urinary stream, urinary retention, hydroceles and phimosis.  

He received both his MD and MPH degrees at St. George’s University, located in Grenada, West Indies. Dr. Atallah subsequently did his urology and general surgery residency at SUNY Downstate University Hospital. A fellowship in endourology was completed at the Mount Sinai Health System under Dr. Mantu Gupta, Director of Endourology and Stone Disease at Mount Sinai. 

During his fellowship, he won 1st place in the Clinical Category of the Annual Essay Contest of the Endourological Society and was asked to speak in Paris, France for his work: “A prospective randomized controlled trial comparing the efficacy of low-oxalate diet versus Vitamin B6 and magnesium supplementation versus both in idiopathic hyperoxaluria”.

Currently a member of the American Medical Association (AMA), the American Urological Association (AUA), and the Endourological Society, he has published his work and presented at multiple conferences.  At the AUA general conference, he presented his work about the impact of African-American race on outcomes after prostatectomy in an equal access center. In Vancouver, Canada at the World Congress of Endourology, he presented on how Continuing Aspirin Does Not Increase Blood Loss from Percutaneous Nephrolithotomy.